CE vs GOSS · rev $10.28B vs rev $114.7M
Celanese Corporation (CE) versus Gossamer Bio Inc (GOSS) — a side-by-side from cached financials, not a winner call.
Celanese Corporation (CE) is a chemicals company listed on US.
Gossamer Bio Inc (GOSS) is a biotechnology company listed on US.
Latest reported CE revenue for 2024-12-31 was $10.28B. Net income was -$1.51B. Revenue was down 6.0% from 2023-12-31 to 2024-12-31. CE currently screens at market cap $5.92B.
Latest reported GOSS revenue for 2024-12-31 was $114.7M. Net income was -$56.5M. GOSS currently screens at market cap $47.0M.
CE currently screens at market cap $5.92B. GOSS currently screens at market cap $47.0M.
Not investment advice. Open the CE and GOSS stock pages for the full models.
Not investment advice.